5-carboxamidotryptamine has been researched along with sb-656104-a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glennon, RA | 1 |
Deeks, NJ; Eddershaw, PJ; Fenwick, SH; Forbes, IT; Gribble, AD; Hagan, JJ; Hill, MJ; Jeffrey, P; Massagrande, M; Melotto, S; Middlemiss, DN; Price, GW; Riley, G; Scott, CM; Stean, T; Stevens, AJ; Thomas, DR | 1 |
1 review(s) available for 5-carboxamidotryptamine and sb-656104-a
Article | Year |
---|---|
Higher-end serotonin receptors: 5-HT(5), 5-HT(6), and 5-HT(7).
Topics: Animals; Humans; Ligands; Receptors, Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 2003 |
1 other study(ies) available for 5-carboxamidotryptamine and sb-656104-a
Article | Year |
---|---|
SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats.
Topics: Animals; Cell Line; Cell Membrane; CHO Cells; Cricetinae; Cyclic AMP; Drug Administration Routes; Gene Expression Regulation; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Humans; Hypothermia; Phenols; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Sleep, REM; Tritium | 2003 |